/Richard Christopher/ - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Executive Officer, Director
Signature
/Richard Christopher/
Issuer symbol
LEXX
Transactions as of
29 Jul 2025
Net transactions value
+$13,641
Form type
4
Filing time
30 Jul 2025, 11:14:34 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHRISTOPHER RICHARD Chief Executive Officer, Director C/O LEXARIA BIOSCIENCE CORP., 100 - 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Richard Christopher/ 30 Jul 2025 0001271244

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $13,641 +15,000 +30% $0.9094 65,000 29 Jul 2025 Direct
holding LEXX common shares 50,000 29 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 200,000 29 Jul 2025 Common Shares 200,000 $3.92 Direct F1
holding LEXX Stock Options 350,000 29 Jul 2025 Common Shares 150,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable December 31, 2026